Patents Assigned to Gongwin Biopharm Holdings Co., Ltd.
  • Topical formulation and method for preventing or treating acne
    Patent number: 10548862
    Abstract: Provided is a topical formulation for preventing or treating acne, including a benzenesulfonamide derivative, and a pharmaceutically or cosmetically acceptable excipient. Also provided is a method for preventing or treating acne, including applying the topical formulation on skin of a subject in need thereof.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: February 4, 2020
    Assignees: Gongwin Biopharm Holdings Co., Ltd.
    Inventors: Chuan-Ching Yang, Mao-Yuan Lin, Tai-Jung Wu, Chi-Chiang Tu, Shun-Chi Wu
  • Benzenesulfonamide derivatives and method for treating cancer
    Patent number: 10485773
    Abstract: Provided are benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof. Also provided is a method for treating cancer by using a pharmaceutical composition including the benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: November 26, 2019
    Assignee: GONGWIN BIOPHARM HOLDINGS CO., LTD.
    Inventors: Chuan-Ching Yang, Shun-Chi Wu, Nanshan Zhong, Mao-Yuan Lin, Chi-Chiang Tu, On Lee
  • Benzenesulfonamide compositions for treatment of malignant pleural effusions
    Patent number: 10182998
    Abstract: The present disclosure provides a novel pharmaceutical composition for treating a malignant pleural effusion (MPE), including a benzenesulfonamide derivative and a pharmaceutically acceptable excipient. The present disclosure further provides a method for treating MPE by using the pharmaceutical composition.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: January 22, 2019
    Assignee: Gongwin Biopharm Holdings Co., Ltd.
    Inventors: Chuan-Ching Yang, Mao-Yuan Lin
  • Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
    Patent number: 9782370
    Abstract: Provided is a method for treating adenoid cystic carcinoma by using a pharmaceutical composition including benzenesulfonamide derivatives and pharmaceutically acceptable carriers.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: October 10, 2017
    Assignee: Gongwin Biopharm Holdings Co., Ltd.
    Inventors: Chuan-Ching Yang, Nanshan Zhong, Mao-Yuan Lin, Chi-Chiang Tu, Kun-Hung Chen, Chia-Yen Hsiao
  • Benzenesulfonamides compositions for treatment of malignant pleural effusions
    Patent number: 9668990
    Abstract: The present disclosure provides a novel pharmaceutical composition for treating a malignant pleural effusion (MPE), including a benzenesulfonamide derivative and a pharmaceutically acceptable excipient. The present disclosure further provides a method for treating MPE by using the pharmaceutical composition.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: June 6, 2017
    Assignee: Gongwin Biopharm Holdings Co., Ltd.
    Inventors: Chuan-Ching Yang, Mao-Yuan Lin